Specialising in the development and registration of biopharmaceuticals

Bioregulatory Consulting (BRC) is based in Melbourne, Australia and has provided a specialised regulatory and development consultancy service to the biotech and pharmaceutical industry since 2002.

Our Purpose

Bioregulatory Consulting’s purpose is to enable the entry of new medicines into the marketplace to facilitate better health outcomes for patients.


With more than 20 years’ experience in development and registration of novel biopharmaceuticals, vaccines, blood products, generics and biosimilars, we understand the multifaceted nature of drug development and the necessity to consider the broad issues.

BRC’s clients include biotech and pharma companies looking to develop novel therapies, generics or biosimilars for registration in the US, EU and/or Australia.

BRC has expertise in development and registration of the following therapies:

  • Monoclonal antibodies

  • Recombinant Viral Vectors

  • Vaccines

  • Biosimilars

  • Generics

  • Recombinant Proteins

  • Blood Products

Contact us for an obligation-free discussion about how we can assist with your project.